DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
DRNA
Delisted
DRNA was delisted on the 27th of December, 2021.
36 hedge funds and large institutions have $36.7M invested in Dicerna Pharmaceuticals, Inc. in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
36
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.22M | |
| 2 | +$81.1K | |
| 3 | +$78K | |
| 4 |
BC
Birchview Capital
Burlington,
Vermont
|
+$63K |
| 5 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$61.5K |
Top Sellers
| 1 | -$1.31M | |
| 2 | -$96K | |
| 3 | -$86K | |
| 4 |
Morgan Stanley
New York
|
-$78.7K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$78K |